Sara Verschleisser

Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS

Y. Mechref, A. Singal, D. Lubman, 2023, ACS omega.

PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer.

Y. Hoshida, A. Yopp, Yunguan Wang, 2024, Cell metabolism.